


DolCas Biotech Revenue
Wellness and Fitness Services • Ledgewood, New Jersey, United States • 11-20 Employees
DolCas Biotech revenue & valuation
| Annual revenue | $10,000,000 |
| Revenue per employee | $589,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Wellness and Fitness Services industry and current estimated revenues | $32,000,000 |
| Total funding | No funding |
Key Contacts at DolCas Biotech
Kg Rao
Chief Executive Officer
Cheryl Dicks
Director Of Operations And Regualtory Affairs
Company overview
| Headquarters | 9 Lenel Road, Lenel Road, Landing, NEW JERSEY 07850, US |
| Phone number | +15001000 |
| Website | |
| SIC | 873 |
| Keywords | Dietary Supplements, Wellness, Nutraceuticals, Education, Marketing, Product Development, Botanicals, Functional Ingredients, Product Positioning, Branded Ingredients, Patented Ingredients, Researched Ingredients |
| Founded | 2007 |
| Employees | 11-20 |
| Socials |
DolCas Biotech Email Formats
DolCas Biotech uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@dolcas-biotech.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@dolcas-biotech.com | 100% |
About DolCas Biotech
DolCas Biotech is a natural products ingredient firm, specializing in the commercial development and market positioning of clinically studied, patented brands. As an invested partner through the entire process, DolCas directs the evolution of science that supports these ingredients, the safety evaluations that bring assurance to the end-consumer and the marketing and service support that fuels innovation and growth for its customers. DolCas Biotech was established in 2007 as an extension of its founding corporation Orcas Naturals. With an already developed acumen in the area of generic powders and extracts trading, the pioneering vision for DolCas was a timely response to the then budding interest in branded nutraceuticals. Pivoting successfully would require a more attentive focus on customers, a more thorough understanding of science and an evolving sense of the prevailing trends of the industry - and DolCas dived in head-first. It expanded and enriched its teams, endeavored to spearhead scientific inquiry on its brands through internal investments and prioritized portfolio development and diversification by setting, versus following industry trends. DolCas expanded its scope, becoming vertically integrated with the establishment of its own manufacturing facilities in Bikaner, India – DolCas Botanosys, in 2017. With a bespoke portfolio of seven, novel, science-substantiated brands, DolCas Biotech is looking to expand its offering of patented, clinically-studied, health benefit ingredients over the next 5 years, both by partnership and internal ingenuity. Recently acknowledged by the globally recognized business and technology magazine The Silicon Review as one of 2020’s ’50 Most Innovative Companies to Watch', DolCas is excited to expound on its commitments to produce, procure and promote brands with the highest possible quality and safety standards and do our part in helping people transform their lives through health and wellness.
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
DolCas Biotech has 6 employees across 5 departments.
Departments
Number of employees
Funding Data
DolCas Biotech has never raised funding before.
DolCas Biotech Tech Stack
Discover the technologies and tools that power DolCas Biotech's digital infrastructure, from frameworks to analytics platforms.
CDN
Advertising
CDN
JavaScript libraries
Databases
Reverse proxies
Programming languages
Hosting
Blogs
Page builders
JavaScript libraries
Mobile frameworks
Frequently asked questions
4.8
40,000 users



